Revolution Medicines Inc (RVMD)
38.87
-0.19
(-0.49%)
USD |
NASDAQ |
May 07, 16:00
38.87
0.00 (0.00%)
After-Hours: 20:00
Revolution Medicines Free Cash Flow: -358.30M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -358.30M |
| September 30, 2023 | -300.08M |
| June 30, 2023 | -252.32M |
| March 31, 2023 | -242.32M |
| December 31, 2022 | -235.22M |
| September 30, 2022 | -211.00M |
| June 30, 2022 | -192.78M |
| March 31, 2022 | -169.93M |
| December 31, 2021 | -153.71M |
| Date | Value |
|---|---|
| September 30, 2021 | -139.46M |
| June 30, 2021 | -130.13M |
| March 31, 2021 | -115.20M |
| December 31, 2020 | -103.00M |
| September 30, 2020 | -88.96M |
| June 30, 2020 | -76.21M |
| March 31, 2020 | -67.88M |
| December 31, 2019 | -52.20M |
Free Cash Flow Range, Past 5 Years
-358.30M
Minimum
Dec 2023
-52.20M
Maximum
Dec 2019
-169.92M
Average
-153.71M
Median
Dec 2021
Free Cash Flow Benchmarks
| Cutera Inc | -170.88M |
| BioSig Technologies Inc | -17.50M |
| TRACON Pharmaceuticals Inc | 3.676M |
| Zentalis Pharmaceuticals Inc | -208.40M |
| Day One Biopharmaceuticals Inc | -150.08M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -120.56M |
| Cash from Investing (Quarterly) | -380.40M |
| Cash from Financing (Quarterly) | 839.35M |
| Free Cash Flow Per Share (Quarterly) | -0.8685 |
| Free Cash Flow to Equity (Quarterly) | -122.88M |
| Free Cash Flow to Firm (Quarterly) | -122.88M |
| Free Cash Flow Yield | -8.15% |